Nurse Practitioner, Family · Montgomery, AL
NPI
1871934984
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
4126 Carmichael Ct
Montgomery, AL, 36106
Phone (334) 239-9257
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
11,126 services
Medicare patients, 2024
393
Average age 74
Drug cost, 2024
$2.7M
5,831 prescriptions
Company payments, 2025
$5,486
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley C Morrow was code 99214 (office e&m - established), 499 times for 320 patients. In total Ashley C Morrow billed 11,126 services in 8 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 499 | 320 | $68.09 | $34K |
| 99204 Office E&M - New | Office | 70 | 70 | $83.06 | $5,814 |
| 99213 Office E&M - Established | Office | 19 | 19 | $41.85 | $795 |
By year: 2022 $92K for 3,155 services; 2023 $191K for 9,041 services; 2024 $217K for 11,126 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashley C Morrow prescribed most often to Medicare patients was Famotidine, with 1,347 prescriptions and refills. In total Ashley C Morrow wrote 5,831 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 1,347 | 2,349 | 334 | $23K |
| Pantoprazole Sodium Generic | 1,243 | 2,383 | 309 | $12K |
| Dicyclomine Hcl Generic | 666 | 853 | 235 | $17K |
| Sucralfate Generic | 389 | 473 | 125 | $17K |
| Linzess Linaclotide | 223 | 437 | 66 | $231K |
| Ondansetron Odt Ondansetron | 197 | 201 | 107 | $3,773 |
| Colestipol Hcl Generic | 170 | 240 | 51 | $17K |
| Omeprazole Generic | 151 | 371 | 48 | $2,865 |
| Metoclopramide Hcl Generic | 144 | 153 | 46 | $2,127 |
| Amitriptyline Hcl Generic | 121 | 248 | 33 | $2,087 |
| Dexlansoprazole Dr Dexlansoprazole | 89 | 184 | 24 | $26K |
| Mesalamine Generic | 87 | 130 | 19 | $69K |
| Spironolactone Generic | 49 | 69 | Under 11 | $664 |
| Stelara Ustekinumab | 41 | 77 | Under 11 | $1.4M |
| Xifaxan Rifaximin | 39 | 39 | Under 11 | $131K |
Brand drugs: 657 claims; generic drugs: 5,174 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley C Morrow $5,486 ($5,486 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $1,302.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 71 | $1,302 |
| Janssen Biotech, Inc. JNJ | 38 | $897 |
| Ardelyx, Inc. ARDX | 22 | $606 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 35 | $493 |
| Madrigal Pharmaceuticals MDGL | 16 | $490 |
| Genzyme Corporation SNY | 10 | $342 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 13 | $216 |
| Lilly USA, LLC LLY | 9 | $213 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.